{
    "clinical_study": {
        "@rank": "98973", 
        "acronym": "PIVKIV", 
        "arm_group": [
            {
                "arm_group_label": "Ketaprofen", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients randomized to this arm will receive intravenous ketaprofen when treating renal colic.\nIntervention: intravenous ketaprofen"
            }, 
            {
                "arm_group_label": "Paracetamol", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized to this arm will receive intravenous paracetamol when treating renal colic.\nIntervention: intravenous paracetamol"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study was to demonstrate the non-inferiority of intravenous\n      paracetamol relative to intravenous ketoprofen when treating renal colic in an emergency\n      ward. Efficacy was measured by the change in visual analog scale for pain at 30 minutes."
        }, 
        "brief_title": "Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Renal Colic", 
            "Acute Renal Colic"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Emergencies", 
                "Renal Colic", 
                "Colic"
            ]
        }, 
        "detailed_description": {
            "textblock": "The secondary objectives of this study are:\n\n        -  To compare the efficacy (non-inferiority) of intravenous paracetamol and ketoprofen at\n           90 minutes (visual analog scale for pain).\n\n        -  To compare both arms in terms of other administered drugs (for pain).\n\n        -  To observe and compare side effects between the two arms: cutaneous manifestation,\n           edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness,\n           disturbance of consciousness, dyspnea, acute retention of urine.\n\n        -  To determine predictors for the use of intravenous morphine when treating renal colic."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient must have given his/her informed and signed consent\n\n          -  The patient must be insured or beneficiary of a health insurance plan\n\n          -  The patient is available for a telephone interview at week 1\n\n          -  Patient consulting at the N\u00eemes University Hospital emergency ward with suspicion of\n             renal colic\n\n        Exclusion Criteria:\n\n          -  The patient is participating in another study\n\n          -  The patient is in an exclusion period determined by a previous study\n\n          -  The patient is under judicial protection, under tutorship or curatorship\n\n          -  The patient refuses to sign the consent\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient is pregnant, parturient, or breastfeeding\n\n          -  The patient has a contraindication for a treatment used in this study\n\n          -  The patient is allergic to paracetamol or ketoprofen\n\n          -  The patient has a fever or is hemodynamically unstable\n\n          -  The patient has a history of aneurysm or aortic dissection, history of renal\n             transplantation, history of renal or hepatic insufficiency\n\n          -  The patient took paracetamol or ketoprofen 4 hours before treating emergencies."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "236", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01685658", 
            "org_study_id": "xxxxxx", 
            "secondary_id": "2012-003994-24"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ketaprofen", 
                "description": "Patients will recieve 100 mg of ketoprofen via slow intravenous perfusion. (100mg of ketoprofen powder for injection dissolved in 100 ml injectable isotonic solution)", 
                "intervention_name": "Intravenous ketoprofen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Paracetamol", 
                "description": "Patients will receive 1g of paracetamol via slow intravenous perfusion. (100 ml of solution at 10mg/ml)", 
                "intervention_name": "Intravenous paracetamol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Ketoprofen"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "N\u00eemes Cedex 9", 
                    "country": "France", 
                    "zip": "30029"
                }, 
                "name": "CHU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
            }, 
            "investigator": {
                "last_name": "Pierre-G\u00e9raud Clarey, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparing the Efficacy of Intravenous Paracetamol and Ketoprofen When Treating Renal Colic in Emergency Situations: a Randomized, Double-blind Controlled Trial", 
        "overall_contact": {
            "email": "pierre.geraud.claret@gmail.com", 
            "last_name": "Pierre-G\u00e9raud Claret, MD", 
            "phone": "+33.(0)4.66.68.80.83"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": {
            "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
            "last_name": "Pierre-G\u00e9raud Claret, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Visual analog scale ranging from 0 to 10.0.", 
            "measure": "Change in visual analog scale for pain", 
            "safety_issue": "Yes", 
            "time_frame": "baseline to 30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01685658"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Visual analog scale ranging from 0 to 10.0.", 
                "measure": "Change in visual analog scale for pain", 
                "safety_issue": "Yes", 
                "time_frame": "baseline to 90 minutes"
            }, 
            {
                "measure": "Was tramadol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "baseline (minute 0)"
            }, 
            {
                "measure": "Was tramadol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "30 minutes"
            }, 
            {
                "measure": "Was tramadol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "90 minutes"
            }, 
            {
                "measure": "Was tramadol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "discharge from emergency ward (estimated max of 24 hours)"
            }, 
            {
                "measure": "Was phloroglucinol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "baseline (minute 0)"
            }, 
            {
                "measure": "Was phloroglucinol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "30 minutes"
            }, 
            {
                "measure": "Was phloroglucinol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "90 minutes"
            }, 
            {
                "measure": "Was phloroglucinol administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "discharge from emergency ward (estimated max of 24 hours)"
            }, 
            {
                "measure": "Was morphine administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "baseline (minute 0)"
            }, 
            {
                "measure": "Was morphine administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "30 minutes"
            }, 
            {
                "measure": "Was morphine administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "90 minutes"
            }, 
            {
                "measure": "Was morphine administered? yes/no", 
                "safety_issue": "No", 
                "time_frame": "discharge from emergency ward (estimated max of 24 hours)"
            }, 
            {
                "description": "cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine", 
                "measure": "Presence/absence of complications", 
                "safety_issue": "Yes", 
                "time_frame": "baseline (minute 0)"
            }, 
            {
                "description": "cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine", 
                "measure": "Presence/absence of complications", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes"
            }, 
            {
                "description": "cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine", 
                "measure": "Presence/absence of complications", 
                "safety_issue": "Yes", 
                "time_frame": "90 minutes"
            }, 
            {
                "description": "cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine", 
                "measure": "Presence/absence of complications", 
                "safety_issue": "Yes", 
                "time_frame": "discharge from emergency ward (estimated max of 24 hours)"
            }, 
            {
                "description": "cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine", 
                "measure": "Presence/absence of complications", 
                "safety_issue": "Yes", 
                "time_frame": "week 1"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}